Carotid intima-media thickness predicts carotid plaque development: Meta-analysis of seven studies involving 9341 participants.


Journal

European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 18 12 2019
revised: 19 02 2020
accepted: 26 02 2020
pubmed: 1 3 2020
medline: 11 3 2021
entrez: 1 3 2020
Statut: ppublish

Résumé

Carotid intima-media thickness and carotid plaque are well-established imaging markers used to capture different stages of the atherosclerotic disease process. We aimed to quantify to which extent carotid intima-media thickness predicts incidence of first-ever carotid plaque. Two independent reviewers conducted a comprehensive literature search of PubMed and Web of Science. To be eligible for inclusion, prospective studies were required to involve participants free of carotid plaque at baseline and report on the association of baseline carotid intima-media thickness with development of first-ever carotid plaque. Study-specific relative risks and 95% confidence intervals were collected and pooled using random-effects meta-analysis. We identified seven relevant prospective studies involving a total of 9341 participants. Individuals were recruited between 1987 and 2012, average age at baseline was 54 years, and 63% were female. Studies reported on 1288 incident first-ever carotid plaques, occurring over an average maximum follow-up of 8.7 years. When individuals in the top fourth of baseline carotid intima-media thickness distribution were compared with those in the bottom fourth, the pooled relative risk for incidence of first-ever carotid plaque was 1.78 (95% confidence interval: 1.53-2.07, P < .001, I In general population studies, elevated baseline carotid intima-media thickness is associated with incidence of carotid plaque in individuals free of carotid plaque at baseline.

Sections du résumé

BACKGROUND BACKGROUND
Carotid intima-media thickness and carotid plaque are well-established imaging markers used to capture different stages of the atherosclerotic disease process. We aimed to quantify to which extent carotid intima-media thickness predicts incidence of first-ever carotid plaque.
MATERIALS AND METHODS METHODS
Two independent reviewers conducted a comprehensive literature search of PubMed and Web of Science. To be eligible for inclusion, prospective studies were required to involve participants free of carotid plaque at baseline and report on the association of baseline carotid intima-media thickness with development of first-ever carotid plaque. Study-specific relative risks and 95% confidence intervals were collected and pooled using random-effects meta-analysis.
RESULTS RESULTS
We identified seven relevant prospective studies involving a total of 9341 participants. Individuals were recruited between 1987 and 2012, average age at baseline was 54 years, and 63% were female. Studies reported on 1288 incident first-ever carotid plaques, occurring over an average maximum follow-up of 8.7 years. When individuals in the top fourth of baseline carotid intima-media thickness distribution were compared with those in the bottom fourth, the pooled relative risk for incidence of first-ever carotid plaque was 1.78 (95% confidence interval: 1.53-2.07, P < .001, I
CONCLUSIONS CONCLUSIONS
In general population studies, elevated baseline carotid intima-media thickness is associated with incidence of carotid plaque in individuals free of carotid plaque at baseline.

Identifiants

pubmed: 32112400
doi: 10.1111/eci.13217
pmc: PMC7187327
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13217

Subventions

Organisme : Dr. Johannes and Hertha Tuba Foundation
Organisme : Austrian Science Fund
ID : P 32488

Informations de copyright

© 2020 The Authors. European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.

Références

Am J Cardiol. 2002 Feb 21;89(4A):10B-15B; discussion 15B-16B
pubmed: 11879661
Circulation. 2007 Jan 30;115(4):459-67
pubmed: 17242284
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
Stroke. 1998 Jul;29(7):1378-82
pubmed: 9660390
South Med J. 2017 Nov;110(11):733-737
pubmed: 29100226
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1159-65
pubmed: 17303781
Stat Med. 1999 Oct 30;18(20):2693-708
pubmed: 10521860
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
J Hum Hypertens. 2019 Sep 23;:
pubmed: 31548615
Atherosclerosis. 2017 Jun;261:169-171
pubmed: 28365003
Circulation. 2004 Mar 9;109(9):1089-94
pubmed: 14993130
Arch Pathol Lab Med. 1988 Oct;112(10):1018-31
pubmed: 3052352
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):177-81
pubmed: 19679833
Stroke. 1993 Dec;24(12):1837-43
pubmed: 8248965
J Am Soc Echocardiogr. 2008 Feb;21(2):93-111; quiz 189-90
pubmed: 18261694
J Neuroimaging. 2014 Sep-Oct;24(5):473-8
pubmed: 25340183
Cerebrovasc Dis. 2012;34(4):290-6
pubmed: 23128470
Atherosclerosis. 2018 Feb;269:57-62
pubmed: 29274849
JAMA. 2012 Aug 22;308(8):796-803
pubmed: 22910757
Atherosclerosis. 2011 Dec;219(2):917-24
pubmed: 22005196
Stroke. 2002 Dec;33(12):2916-22
pubmed: 12468791
Stroke. 2013 Aug;44(8):2101-8
pubmed: 23704105
Brain Behav. 2017 Oct 12;7(11):e00847
pubmed: 29201548
Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):310-6
pubmed: 8620348
Atherosclerosis. 1996 Jan 5;119(1):7-15
pubmed: 8929258
J Am Soc Nephrol. 2008 Apr;19(4):757-63
pubmed: 18184855
Stroke. 2012 Jul;43(7):1818-23
pubmed: 22550052
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Chin Med J (Engl). 2016 Jan 20;129(2):215-26
pubmed: 26830994
J Hypertens. 2015 Dec;33(12):2471-6
pubmed: 26378685
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38
pubmed: 25051948
Atherosclerosis. 2015 Aug;241(2):364-70
pubmed: 26071659
Nephron. 2017;136(2):111-120
pubmed: 28237990
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):287-96
pubmed: 26668022
JAMA. 1998 May 13;279(18):1477-82
pubmed: 9600484
Int J Stroke. 2006 Nov;1(4):216-21
pubmed: 18706019
Nat Commun. 2018 Dec 3;9(1):5141
pubmed: 30510157
Stroke. 2005 Apr;36(4):715-9
pubmed: 15746459
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1622-9
pubmed: 10845881
Am J Epidemiol. 1996 Sep 15;144(6):610-21
pubmed: 8797521
Arterioscler Thromb. 1994 Feb;14(2):261-4
pubmed: 8305418
Nat Genet. 2011 Sep 11;43(10):940-7
pubmed: 21909108
Eur J Clin Invest. 2010 Jan;40(1):35-53
pubmed: 20055895
Cardiovasc Ultrasound. 2008 Mar 05;6:10
pubmed: 18321381
Circulation. 1986 Dec;74(6):1399-406
pubmed: 3536154
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Int J Cardiol Heart Vasc. 2015 Aug 08;9:48-51
pubmed: 28785705
Int J Cardiol. 2018 Sep 1;266:245-249
pubmed: 29887456
Atherosclerosis. 2012 Jan;220(1):128-33
pubmed: 21764060
Atherosclerosis. 2011 Aug;217(2):437-40
pubmed: 21570076
Cerebrovasc Dis. 2006;22(5-6):416-22
pubmed: 16912475
Hypertension. 2003 Mar;41(3):519-27
pubmed: 12623953
Eur J Clin Invest. 2020 Apr;50(4):e13217
pubmed: 32112400
Am J Med. 2009 Jan;122(1 Suppl):S3-S14
pubmed: 19110086
Stroke. 2010 Oct;41(10):2375-7
pubmed: 20814002
Hypertens Res. 2014 Oct;37(10):960-5
pubmed: 24804610
BMC Cardiovasc Disord. 2009 Dec 22;9:55
pubmed: 20028534
Stroke. 1997 Mar;28(3):665-71
pubmed: 9056629
Stroke. 1999 Apr;30(4):841-50
pubmed: 10187889
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Lena Tschiderer (L)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Gerhard Klingenschmid (G)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Lisa Seekircher (L)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Peter Willeit (P)

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH